Home › Essential Thrombocythemia › Alabama › Birmingham
Essential Thrombocythemia clinical trials in Birmingham, AL
3 studies for Essential Thrombocythemia are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- University of Alabama At Birmingham, Birmingham
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- University of Alabama At Birmingham Comprehensive Cancer Center, Birmingham
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
RecruitingPhase 1
- Site US07, Birmingham
Essential Thrombocythemia trials in other cities
- New York City, NY8 studies
- Durham, NC7 studies
- Nashville, TN5 studies
- Salt Lake City, UT5 studies
- Boston, MA5 studies
- Baltimore, MD5 studies
- Mountain View, CA4 studies
- Irvine, CA4 studies
- Columbus, OH4 studies
- Miami, FL4 studies
- Chicago, IL4 studies
- Houston, TX4 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Ovarian Cancer25 studies
- Breast Cancer24 studies
- Non-Small Cell Lung Cancer23 studies
- Obesity22 studies
- Acute Myeloid Leukemia21 studies
- COPD17 studies
- Multiple Myeloma17 studies
- Cardiovascular Disease16 studies
- Endometrial Cancer16 studies
- Overweight16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.